584.25MMarket Cap33.05P/E (TTM)
20.580High19.595Low470.88KVolume20.020Open20.030Pre Close9.49MTurnover1.70%Turnover Ratio33.05P/E (Static)28.51MShares35.84052wk High1.28P/B568.03MFloat Cap16.96552wk Low--Dividend TTM27.72MShs Float107.690Historical High--Div YieldTTM4.92%Amplitude9.260Historical Low20.151Avg Price1Lot Size
Castle Biosciences Stock Forum
New Data at ASTRO 2024 Shows Castle Biosciences’ DecisionDx®-SCC Test Provides More Precise Risk Stratification Than BWH Staging Alone to Guide Intensified Treatment for Immune Suppressed Patients with High-Risk Cutaneous Squamous Cell Carcinoma | CSTL Stock News
Businesswire· 4 mins ago
No comment yet